RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride

Brain Research Bulletin

Volumn 98, Issue , 2013, Pages 132-144

  Del Olmo Aguado, Susana ^a   Núñez Álvarez, Claudia ^a   Ji, Dan ^b   Manso, Alberto García ^a   Osborne, Neville N ^a,b  

^a Fundacion de Investigacion Oftalmologica   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blue light; Chemical hypoxia; Ganglion cells; Neuroprotection; Rapamycin; RTP801

Indexed keywords

COBALT CHLORIDE; HEAT SHOCK PROTEIN; RAPAMYCIN; RTP801 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLUE LIGHT; CELL ASSAY; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; IMMUNOREACTIVITY; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; UPREGULATION;

BLUE LIGHT; CHEMICAL HYPOXIA; GANGLION CELLS; NEUROPROTECTION; RAPAMYCIN; RTP801;

ANIMALS; ANTIMUTAGENIC AGENTS; APOPTOSIS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL LINE, TRANSFORMED; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIGHT; MICE; PROTON IONOPHORES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; RETINA; RETINAL GANGLION CELLS;

EID: 84883661845     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.08.002     Document Type: Article

References (50)

1. Albarracin R., Eells J., Valter K. Photobiomodulation protects the retina from light-induced photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:3582-3592.
2. Albarracin R., Valter K. 670nm red light preconditioning supports Muller cell function: evidence from the white light-induced damage model in the rat retina. Photochem. Photobiol. 2012, 88:1418-1427.
3. Arachchige Don A.S., Tsang C.K., Kazdoba T.M., D'Arcangelo G., Young W., Steven Zheng X.F. Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries. Drug Discov. Today 2012, 17:861-868.
4. Begum R., Powner M.B., Hudson N., Hogg C., Jeffery G. Treatment with 670nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS ONE 2013, 8:e57828.
5. Bové J., Martínez-Vicente M., Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat. Rev. Neurosci. 2011, 12:437-452.
6. Brafman A., Mett I., Shafir M., Gottlieb H., Damari G., Gozlan-Kelner S., Vishnevskia-Dai V., Skaliter R., Einat P., Faerman A., Feinstein E., Shoshani T. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Invest. Ophthalmol. Vis. Sci. 2004, 45:3796-3805.
7. Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012, 31:702-719.
8. Carter W.O., Narayanan P.K., Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 1994, 55:253-258.
9. Chung J., Kuo C.J., Crabtree G.R., Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kd S6 protein kinases. Cell 1992, 69:1227-1236.
10. Corradetti M.N., Inoki K., Guan K.-L. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 2005, 280:9769-9772.
11. Dejneka N.S., Kuroki A.M., Fosnot J., Tang W., Tolentino M.J., Bennett J. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol. Vis. 2004, 10:964-972.
12. Del Olmo-Aguado S., Manso A.G., Osborne N.N. Light might directly affect retinal ganglion cell mitochondria to potentially influence function. Photochem. Photobiol. 2012, 88:1346-1355.
13. DeYoung M.P., Horak P., Sofer A., Sgroi D., Ellisen L.W. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 2008, 22:239-251.
14. Dudek H., Datta S.R. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275:661.
15. Dudel J., Adelsberger H., Heckmann M. Neuromuscular glutamatergic and GABAergic channels. Invert. Neurosci. 1997, 3:89-92.
16. Ellisen L.W., Ramsayer K.D., Johannessen C.M., Yang A., Beppu H., Minda K., Oliner J.D., McKeon F., Haber D.A. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 2002, 10:995-1005.
17. Franke T.F., Kaplan D.R., Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 1997, 88:435-437.
18. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997, 275:665-668.
19. Horak P., Crawford A.R., Vadysirisack D.D., Nash Z.M., DeYoung M.P., Sgroi D., Ellisen L.W. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4675-4680.
20. Jacinto E., Lorberg A. TOR regulation of AGC kinases in yeast and mammals. Biochem. J. 2008, 410:19-37.
21. Ji D., Kamalden T.A., del Olmo-Aguado S., Osborne N.N. Light- and sodium azide-induced death of RGC-5 cells in culture occurs via different mechanisms. Apoptosis 2011, 16:425-437.
22. Katiyar S., Liu E., Knutzen C.A., Lang E.S., Lombardo C.R., Sankar S., Toth J.I., Petroski M.D., Ronai Z., Chiang G.G. REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase. EMBO Rep. 2009, 10:866-872.
23. Krishnamoorthy R.R., Agarwal P., Prasanna G., Vopat K., Lambert W., Sheedlo H.J., Pang I.H., Shade D., Wordinger R.J., Yorio T., Clark A.F., Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res. Mol. Brain Res. 2001, 86:1-12.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122:3589-3594.
26. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
27. Levkovitch-Verbin H., Harizman N., Dardik R., Nisgav Y., Vander S., Melamed S. Regulation of cell death and survival pathways in experimental glaucoma. Exp. Eye Res. 2007, 85:250-258.
28. Malagelada C., Jin Z.H., Greene L.A. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J. Neurosci. 2008, 28:14363-14371.
29. Malagelada C., Jin Z.H., Jackson-Lewis V., Przedborski S., Greene L.A. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J. Neurosci. 2010, 30:1166-1175.
30. Malagelada C., Lopez-Toledano M.A., Willett R.T., Jin Z.H., Shelanski M.L., Greene L.A. RTP801/REDD1 regulates the timing of cortical neurogenesis and neuron migration. J. Neurosci. 2011, 31:3186-3196.
31. Malagelada C., Ryu E.J., Biswas S.C., Jackson-Lewis V., Greene L.A. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J. Neurosci. 2006, 26:9996-10005.
32. Manabe S.-I., Lipton S.A. Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest. Ophthalmol. Vis. Sci. 2003, 44:385-392.
33. Marras C., Lang A. Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain. Neurology 2008, 70:1996-2003.
34. Molitoris J.K., McColl K.S., Swerdlow S., Matsuyama M., Lam M., Finkel T.H., Matsuyama S., Distelhorst C.W. Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J. Biol. Chem. 2011, 286:30181-30189.
35. Nakazawa T., Shimura M., Endo S., Takahashi H., Mori N., Tamai M. N-methyl-d-aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. Mol. Vis. 2005, 11:1173-1182.
36. Osborne N.N. Pathogenesis of ganglion cell death in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog. Brain Res. 2008, 173:339-352.
37. Osborne N.N. Mitochondria, their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 2010, 90:750-757.
38. Osborne N.N., Li G.Y., Ji D., Mortiboys H.J., Jackson S.J. Light affects mitochondrial to cause apoptosis in cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J. Neurochem. 2008, 105:2013-2028.
39. Osborne N.N., Lascaratos G., Bron A.J., Chidlow G., Wood J.P. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br. J. Ophthalmol. 2006, 90:237-241.
40. Pong K., Zaleska M.M. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. Curr. Drug Targets CNS Neurol. Disord. 2003, 2:349-356.
41. Rüegg S., Baybis M., Juul H., Dichter M., Crino P.B. Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons. Epilepsy Res 2007, 77:85-92.
42. Schramm M., Eimerl S., Costa E. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-d-aspartate. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1193-1197.
43. Schratt G.M., Nigh E.A., Chen W.G., Hu L., Greenberg M.E. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 2004, 24:7366-7377.
44. Schwarzer R., Tondera D., Arnold W., Giese K., Klippel A., Kaufmann J. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 2005, 24:1138-1149.
45. Shoshani T., Faerman A., Mett I., Zelin E., Tenne T., Gorodin S., Moshel Y., Elbaz S., Budanov A., Chajut A., Kalinski H., Kamer I., Rozen A., Mor O., Keshet E., Leshkowitz D., Einat P., Skaliter R., Feinstein E. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell. Biol. 2002, 22:2283-2293.
46. Sofer A., Lei K., Johannessen C.M., Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 2005, 25:5834-5845.
47. Terada N., Patel H.R., Takase K., Kohno K., Nairn A.C., Gelfand E.W. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:11477-11481.
48. Wan X., Harkavy B., Shen N., Grohar P., Helman L.J. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 2007, 26:1932-1940.
49. Wang W., Yang X., López de Silanes I., Carling D., Gorospe M. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 2003, 278:27016-27023.
50. Yoshida T., Mett I., Bhunia A.K., Bowman J., Perez M., Zhang L., Gandjeva A., Zhen L., Chukwueke U., Mao T., Richter A., Brown E., Ashush H., Notkin N., Gelfand A., Thimmulappa R.K., Rangasamy T., Sussan T., Cosgrove G., Mouded M., Shapiro S.D., Petrache I., Biswal S., Feinstein E., Tuder R.M. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat. Med. 2010, 16:767-773.